Keng Teng Tan
Overview
Explore the profile of Keng Teng Tan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
93
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tang J, Teng P, Chen C, Tan K, Ang W, Lau S, et al.
Arch Public Health
. 2024 Mar;
82(1):37.
PMID: 38500190
Background: Potentially inappropriate prescribing is common among older adults with multimorbidity due to various reasons, from concurrent application of multiple single-disease clinical guidelines to fragmentation of care. Interventions such as...
2.
Teng P, Lun P, Tang J, Tan K, Ang W, Ding Y
Arch Gerontol Geriatr
. 2023 Jul;
115:105110.
PMID: 37418820
Background And Objectives: This article discusses the development process of an intervention to facilitate appropriate prescribing for older adults with multimorbidity at geriatric medicine outpatient clinics. Both effectiveness and implementability...
3.
Optimising prescribing practices in older adults with multimorbidity: a scoping review of guidelines
Lun P, Law F, Ho E, Tan K, Ang W, Munro Y, et al.
BMJ Open
. 2021 Dec;
11(12):e049072.
PMID: 34907045
Objective: Inappropriate polypharmacy occurs when multiple medications are prescribed without clear indications or where harms outweigh their benefits. The aims of this scoping review are to (1) identify prescribing guidelines...
4.
Tang J, Lun P, Teng P, Ang W, Tan K, Ding Y
Eur Geriatr Med
. 2021 Oct;
13(3):531-539.
PMID: 34647238
Purpose: Potentially inappropriate prescribing among older adults is a rising concern, attributed mainly by polypharmacy and multimorbidity. We aimed to identify key components and strategies for construction of a context-relevant...
5.
Lun P, Tang J, Lee J, Tan K, Ang W, Ding Y
Aging Med (Milton)
. 2021 Sep;
4(3):180-192.
PMID: 34553115
Objectives: We aimed to understand the barriers experienced by physicians when prescribing for older adults with multimorbidity in specialist outpatient clinics in Singapore. Methods: A modified Delphi study was conducted...
6.
Lau S, Lun P, Ang W, Tan K, Ding Y
BMC Geriatr
. 2020 Nov;
20(1):459.
PMID: 33167898
Background: As the population ages, potentially inappropriate prescribing (PIP) in the older adults may become increasingly prevalent. This undermines patient safety and creates a potential source of major morbidity and...
7.
Lee J, Ying K, Lun P, Tan K, Ang W, Munro Y, et al.
BMJ Open
. 2020 Aug;
10(8):e039543.
PMID: 32819958
Objective: Polypharmacy occurs in approximately 30% of older adults aged 65 years or more, particularly among those with multimorbidity. With polypharmacy, there is an associated risk of potentially inappropriate prescribing...
8.
Cheong S, Ng T, Tan K
Eur J Hosp Pharm
. 2019 Jun;
25(e1):e35-e39.
PMID: 31157064
Objectives: Deprescribing can help reduce polypharmacy in the elderly and hospitalisation presents an opportunity to re-evaluate the use of medications. The aim of this study was to describe the drugs...
9.
Zhao Y, Lin L, Zhou H, Tan K, Chew A, Foo C, et al.
Int J Cardiol
. 2016 Jul;
220:794-801.
PMID: 27400183
Background: Novel oral anticoagulants (NOACs) expand the treatment options for patients with atrial fibrillation (AF). Their benefits need to be weighed against the risk-benefit ratio in real-world elderly patients, prompting...
10.
Lin L, Lim W, Zhou H, Khoo A, Tan K, Chew A, et al.
J Am Med Dir Assoc
. 2015 Nov;
16(12):1103.e1-19.
PMID: 26527225
Introduction: Novel oral anticoagulants (NOACs) expanded the options for stroke prevention in atrial fibrillation (AF). Earlier studies comparing their relative effectiveness and safety typically do not incorporate age-related differences or...